Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-109761·IGM Biosciences, Inc.
Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.01 per share · CUSIP: 449585108
Event date: 2025-08-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Topsoe Holding A/SReported CIK 0001788357
Shares: 0 · Class: 0%
- Jakob Haldor Topsoe
Shares: 0 · Class: 0%
- Christina Teng Topsoe
Shares: 0 · Class: 0%
- Anne Haugwitz-Hardenberg-Reventlow
Shares: 0 · Class: 0%
- Emil Oigaard
Shares: 0 · Class: 0%
- Thomas Schleicher
Shares: 0 · Class: 0%
- Birgitte Nielsen
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-109761
- Form type
- SCHEDULE 13D/A
- Filer
- IGM Biosciences, Inc.
- CIK
- CIK 1496323
- Filed
- Aug 18, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13D beneficial ownership